Article

Cleanser derived from tea-tree oil

A new moist towlette from Bio-Tissue Inc. contains Cliradex, a preparation derived from tea-tree oil that can be used for regular eyelash and eyelid skin cleansing.

 

Miami-Bio-Tissue Inc, announces the introduction of Cliradex, a new preservative-free, all-natural lid and lash cleanser. Packaged as a moist towlette, the preparation can be used for regular eyelash and eyelid skin cleansing that is important for patients with eye conditions such as blepharitis, ocular rosacea, dry eye, and conjunctivitis.

The key constituents of the proprietary formulation are derived from the oil of the tea tree, Melaleuca alternifolia, have been studied extensively around the world, and have demonstrated numerous eye, skin, and overall cleansing benefits.

 “With the active ingredient of tea tree oil, Cliradex is a great alternative for patients seeking to improve overall eye and skin health without harmful chemical preservatives,” said Scheffer C.G. Tseng, MD, PhD, medical director of Bio-Tissue Inc., and medical director of Ocular Surface Center, Miami. “Regular eyelash and eyelid skin cleansing is important for people with eye conditions . . . [that] if ignored can lead to serious problems, including impaired vision and an increased risk of eye infection.”

 

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.